She received her Ph.D. in biochemistry in 2013 at Uppsala University. She is interested in protein drug designs and is designing proteins so that they can pass the blood brain barrier or to reach specific cellular compartments. She has developed an antibody format that enter the brain 80 times better than a normal antibody and that is functional as a diagnostic marker for Alzheimer's disease.